Let’s be brutally honest: the traditional event experience is fundamentally broken. It is a relic of […]
On December 12, 2025, Japan’s Ministry of Health, Labour and Welfare (MHLW) tabled a draft outline […]
You fly in, you present, you charm the room. Heads nod. The technical team likes your […]
Japan’s pharmaceutical market is about to run a high-stakes experiment in how hard a mature health […]
A New Order is taking shape in Japan’s life sciences. Conference floors are packed, university benches […]
An A3 Executive Reference (2 pages) Japan rewards programs that are sequenced, evidenced, and locally socialized. […]
Cracking Japan’s Pharma Ecosystem: Field Notes from ~20 Years in the Trenches Japan rewards sequencing, proof, […]
As mRNA biotechnology matures, few firms have demonstrated a shift as dynamic as Moderna. Widely recognised […]
In the mid-1990s, Japan was not merely participating in the global pharmaceutical industry—it was shaping it. […]
Just before BioJapan 2025 takes over Pacifico Yokohama (Oct 8–10), another major event for diagnostics, JACLaS […]